Showing 1 - 10 of 91,504
. -- pharmaceuticals ; pharmacies ; generic substitution …We study the impact of product margins on pharmacies' incentive to promote generics instead of brand-names. First, we … construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to purchase a generic …
Persistent link: https://www.econbiz.de/10009691207
We study the impact of product margins on pharmacies' incentive to promote generics instead of brand-names. First, we … construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to purchase a generic … version instead. We show that pharmacies' substitution incentives are determined by relative margins and relative patient …
Persistent link: https://www.econbiz.de/10013139185
We study the impact of product margins on pharmacies' incentive to promote generics instead of brand-names. First, we … construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to purchase a generic … version instead. We show that pharmacies' substitution incentives are determined by relative margins and relative patient …
Persistent link: https://www.econbiz.de/10013088216
I evaluate how the probability of substitution of a prescribed drug in a pharmacy depends on the pharmacists' profits and patients' out of pocket costs. I use Finnish population-wide data covering all prescriptions of three popular antidepressants. I find that one euro increase in the total...
Persistent link: https://www.econbiz.de/10011954334
Persistent link: https://www.econbiz.de/10009762378
We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub-sample of off-patent products. First, we construct a vertical...
Persistent link: https://www.econbiz.de/10010274913
-savings, and that patients' copayments decrease despite the extra surcharges under RP. -- pharmaceuticals ; regulation ; generic …
Persistent link: https://www.econbiz.de/10008749029
We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub-sample of off-patent products. First, we construct a vertical...
Persistent link: https://www.econbiz.de/10013316129
Policy makers use reference pricing to curb pharmaceutical expenditures by reducing coverage of expensive branded drugs. In a theoretical analysis we show that the net effect of reference pricing is generally ambiguous when accounting for entry by generic producers. Reference pricing shifts...
Persistent link: https://www.econbiz.de/10013285854
We study the impact of product margins on pharmacies’ incentive to promote generics instead of brand-names. First, we … construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to purchase a generic … version instead. We show that pharmacies’ substitution incentives are determined by relative margins and relative patient …
Persistent link: https://www.econbiz.de/10010603857